Carl Byrnes

Stock Analyst at Northland Capital Markets

(0)
# 3109
Out of 5,267 analysts
31
Total ratings
43.75%
Success rate
4.91%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
BioLife Solns
Maintains: Outperform
28 31
23.99 29.22% 2 Jan 8, 2025
TriSalus Life Scienc...
Initiates Coverage On: Outperform
13
5.74 117.77% 1 Oct 25, 2024
BrainsWay
Maintains: Outperform
11 13
9.48 31.86% 3 Oct 3, 2024
Oncternal Therapeuti...
Downgrades: Market Perform
2
n/a n/a 1 Sep 12, 2024
Spectral AI
Initiates Coverage On: Outperform
6
1.74 244.83% 1 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Dec 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
2 2
0.54 131.48% 1 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
8
0.45 1677.78% 1 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 1
n/a n/a 1 Dec 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 18
n/a n/a 2 Sep 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 80
19.66 306.92% 4 Aug 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Nov 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9
n/a n/a 1 Nov 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
9
n/a n/a 1 Oct 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
8.36 175.12% 3 Jul 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
30 24
1.7 1311.76% 4 May 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
128
n/a n/a 1 Apr 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
2000
1.29 154938.76% 1 Oct 22, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Sep 27, 2017